TAG / OZEMPIC
RESULTS
CORRUPTION
Big Pharma Profits While Making Sick Americans Sicker on Designer Weight Loss Drugs
As Novo Nordisk CEO Lars Fruergaard Jørgensen prepares to testify before the Senate on the high cost of his designer weight loss drugs, a simple question remains: How can Big Pharma justify raking in billions exploiting the obesity epidemic while harming Americans?